See more : Palmer Square Capital BDC Inc. (PSBD) Income Statement Analysis – Financial Results
Complete financial analysis of Invacare Corporation (IVC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Invacare Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Medtronic plc (2M6.DE) Income Statement Analysis – Financial Results
- Godfrey Phillips India Limited (GODFRYPHLP.BO) Income Statement Analysis – Financial Results
- USI Corporation (1304.TW) Income Statement Analysis – Financial Results
- Nissan Motor Co., Ltd. (NSANF) Income Statement Analysis – Financial Results
- Aditya Birla Sun Life AMC Limited (ABSLAMC.NS) Income Statement Analysis – Financial Results
Invacare Corporation (IVC)
About Invacare Corporation
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 741.73M | 872.46M | 850.69M | 927.96M | 972.35M | 966.50M | 1.05B | 1.14B | 1.27B | 1.35B | 1.46B | 1.80B | 1.72B | 1.69B | 1.76B | 1.60B | 1.50B | 1.53B | 1.40B | 1.25B | 1.09B | 1.05B | 1.01B | 878.30M | 797.50M | 653.40M | 619.50M | 504.00M | 411.10M | 365.50M | 305.20M | 263.20M | 229.80M | 186.10M | 160.80M | 130.80M | 111.50M | 94.30M |
| Cost of Revenue | 566.34M | 633.35M | 605.44M | 665.90M | 704.67M | 697.25M | 763.85M | 829.51M | 922.78M | 974.89M | 1.01B | 1.28B | 1.21B | 1.20B | 1.27B | 1.16B | 1.08B | 1.08B | 984.74M | 872.52M | 761.76M | 735.29M | 673.32M | 581.10M | 535.20M | 436.70M | 400.10M | 323.60M | 265.30M | 238.80M | 197.80M | 170.50M | 153.10M | 129.20M | 108.70M | 88.40M | 74.90M | 66.30M |
| Gross Profit | 175.39M | 239.11M | 245.25M | 262.07M | 267.68M | 269.25M | 283.63M | 312.82M | 347.39M | 377.47M | 444.90M | 518.48M | 509.64M | 493.19M | 488.89M | 446.30M | 417.07M | 448.51M | 418.59M | 374.66M | 327.40M | 318.35M | 339.84M | 297.20M | 262.30M | 216.70M | 219.40M | 180.40M | 145.80M | 126.70M | 107.40M | 92.70M | 76.70M | 56.90M | 52.10M | 42.40M | 36.60M | 28.00M |
| Gross Profit Ratio | 23.65% | 27.41% | 28.83% | 28.24% | 27.53% | 27.86% | 27.08% | 27.38% | 27.35% | 27.91% | 30.57% | 28.79% | 29.59% | 29.13% | 27.85% | 27.86% | 27.84% | 29.32% | 29.83% | 30.04% | 30.06% | 30.21% | 33.54% | 33.84% | 32.89% | 33.16% | 35.42% | 35.79% | 35.47% | 34.66% | 35.19% | 35.22% | 33.38% | 30.57% | 32.40% | 32.42% | 32.83% | 29.69% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 422.10M | 411.51M | 0.00 | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 195.57M | 201.54M | 177.60M | 157.60M | 160.10M | 136.10M | 112.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 226.78M | 232.24M | 236.36M | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 422.10M | 411.51M | 398.65M | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 195.57M | 201.54M | 177.60M | 157.60M | 160.10M | 136.10M | 112.20M | 89.30M | 77.50M | 69.80M | 60.90M | 53.30M | 43.10M | 38.10M | 33.30M | 29.20M | 26.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.20M | 40.16M | 2.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.97M | 31.47M | 26.00M | 23.80M | 18.30M | 17.90M | 14.20M | 12.70M | 12.30M | 10.00M | 8.10M | 6.60M | 5.00M | 3.20M | 2.70M | 2.20M | -55.60M |
| Operating Expenses | 226.78M | 232.24M | 236.36M | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 446.30M | 451.68M | 401.52M | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 204.55M | 233.01M | 203.60M | 181.40M | 178.40M | 154.00M | 126.40M | 102.00M | 89.80M | 79.80M | 69.00M | 59.90M | 48.10M | 41.30M | 36.00M | 31.40M | -29.30M |
| Cost & Expenses | 793.12M | 865.59M | 841.79M | 925.96M | 986.58M | 994.06M | 1.07B | 1.15B | 1.31B | 1.38B | 1.43B | 1.73B | 1.66B | 1.60B | 1.67B | 1.52B | 1.45B | 1.42B | 1.28B | 1.13B | 982.06M | 939.84M | 906.33M | 784.70M | 716.60M | 615.10M | 554.10M | 450.00M | 367.30M | 328.60M | 277.60M | 239.50M | 213.00M | 177.30M | 150.00M | 124.40M | 106.30M | 94.30M |
| Interest Income | -56.00K | -1.00K | 93.00K | 429.00K | 534.00K | 473.00K | 265.00K | 165.00K | 507.00K | 384.00K | 685.00K | 1.44M | 724.00K | 1.67M | 0.00 | 0.00 | -2.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 28.52M | 24.31M | 28.50M | 29.08M | 28.34M | 22.91M | 15.88M | 2.91M | 3.04M | 3.51M | 9.12M | 7.96M | 20.65M | 33.15M | 39.23M | 44.31M | 3.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -10.99M | 16.82M | 21.27M | 24.49M | 15.56M | 14.63M | 14.64M | 19.43M | 32.79M | 36.79M | 38.59M | 38.88M | 36.80M | 40.56M | 43.74M | 43.72M | 37.71M | 40.52M | 32.32M | 27.24M | 26.64M | 33.45M | 31.47M | 26.00M | 23.80M | 18.30M | 17.90M | 14.20M | 12.70M | 12.30M | 10.00M | 8.10M | 6.60M | 5.00M | 3.20M | 2.70M | 2.20M | 1.70M |
| EBITDA | -80.47M | 2.01M | 25.33M | 2.01M | -14.23M | -28.71M | -42.86M | 10.86M | -14.69M | 86.01M | 67.78M | 52.43M | 95.49M | 120.99M | 95.25M | 79.46M | 43.22M | 111.83M | 142.69M | 133.64M | 123.17M | 99.84M | 129.69M | 94.00M | 98.90M | 23.60M | 81.70M | 66.10M | 54.60M | 45.80M | 37.50M | 31.00M | 20.50M | 10.00M | 11.60M | 7.50M | 7.50M | 400.00K |
| EBITDA Ratio | -10.85% | 0.23% | 2.98% | 1.03% | 1.01% | -2.97% | 0.09% | 0.95% | -1.16% | 6.36% | 4.66% | 2.91% | 5.55% | 7.15% | 5.42% | 3.63% | -18.14% | 7.31% | 10.17% | 10.72% | 11.31% | 9.48% | 12.80% | 10.70% | 12.40% | 3.61% | 13.19% | 13.12% | 13.28% | 12.53% | 12.29% | 11.78% | 8.92% | 5.37% | 7.21% | 5.73% | 6.73% | 0.42% |
| Operating Income | -69.48M | -14.81M | 11.33M | -10.41M | -18.29M | -40.16M | -15.22M | -7.02M | -36.53M | -24.36M | 30.40M | 12.11M | 57.96M | 78.76M | 90.64M | 79.46M | 43.22M | 99.43M | 121.47M | 112.65M | 107.10M | 113.80M | 106.83M | 93.60M | 80.90M | 38.30M | 65.40M | 54.00M | 43.80M | 36.90M | 27.60M | 23.70M | 16.80M | 8.80M | 10.80M | 6.40M | 5.20M | -1.30M |
| Operating Income Ratio | -9.37% | -1.70% | 1.33% | -1.12% | -1.88% | -4.16% | -1.45% | -0.61% | -2.88% | -1.80% | 2.09% | 0.67% | 3.37% | 4.65% | 5.16% | 4.96% | 2.89% | 6.50% | 8.66% | 9.03% | 9.83% | 10.80% | 10.54% | 10.66% | 10.14% | 5.86% | 10.56% | 10.71% | 10.65% | 10.10% | 9.04% | 9.00% | 7.31% | 4.73% | 6.72% | 4.89% | 4.66% | -1.38% |
| Total Other Income/Expenses | -17.54M | -14.88M | -35.77M | -46.03M | -19.87M | 10.29M | 13.30M | -4.72M | -26.69M | -13.98M | -20.43M | -90.79M | -19.92M | -47.27M | -39.14M | -64.97M | -352.75M | -28.13M | -11.10M | -6.24M | -10.57M | -47.41M | -8.62M | -25.60M | -5.80M | -33.00M | -1.60M | -2.10M | -1.90M | -3.40M | -100.00K | -800.00K | -2.90M | -3.80M | -2.40M | -1.60M | 100.00K | 0.00 |
| Income Before Tax | -98.00M | -39.12M | -24.44M | -44.03M | -34.10M | -66.25M | -29.56M | -11.74M | -63.21M | -38.34M | 9.97M | 5.59M | 38.04M | 47.28M | 51.50M | 14.49M | -309.52M | 71.30M | 110.37M | 106.41M | 96.53M | 66.39M | 98.22M | 68.00M | 75.10M | 5.30M | 63.80M | 51.90M | 41.90M | 33.50M | 27.50M | 22.90M | 13.90M | 5.00M | 8.40M | 4.80M | 5.30M | -1.30M |
| Income Before Tax Ratio | -13.21% | -4.48% | -2.87% | -4.74% | -3.51% | -6.85% | -2.82% | -1.03% | -4.98% | -2.84% | 0.69% | 0.31% | 2.21% | 2.79% | 2.93% | 0.90% | -20.66% | 4.66% | 7.87% | 8.53% | 8.86% | 6.30% | 9.69% | 7.74% | 9.42% | 0.81% | 10.30% | 10.30% | 10.19% | 9.17% | 9.01% | 8.70% | 6.05% | 2.69% | 5.22% | 3.67% | 4.75% | -1.38% |
| Income Tax Expense | 3.07M | 6.45M | 3.84M | 9.30M | 9.82M | 10.29M | 13.30M | 14.71M | 5.55M | 12.66M | 18.24M | 9.70M | 12.70M | 6.10M | 12.95M | 13.30M | 8.25M | 22.45M | 35.18M | 35.00M | 31.76M | 31.20M | 38.31M | 26.50M | 29.30M | 3.70M | 24.90M | 19.70M | 15.50M | 11.40M | 9.80M | 8.80M | 6.30M | 2.40M | 3.30M | 2.40M | 1.90M | -200.00K |
| Net Income | -101.07M | -45.56M | -28.28M | -53.33M | -43.92M | -76.54M | -42.86M | -26.19M | -56.07M | 33.05M | 1.83M | -4.11M | 25.34M | 41.18M | 38.55M | 1.19M | -317.77M | 48.85M | 75.20M | 71.41M | 64.77M | 35.19M | 59.91M | 41.50M | 45.80M | 1.60M | 38.90M | 32.20M | 26.40M | 22.10M | 17.70M | 14.10M | 7.60M | 2.60M | 5.10M | 2.40M | 3.40M | -1.10M |
| Net Income Ratio | -13.63% | -5.22% | -3.32% | -5.75% | -4.52% | -7.92% | -4.09% | -2.29% | -4.41% | 2.44% | 0.13% | -0.23% | 1.47% | 2.43% | 2.20% | 0.07% | -21.21% | 3.19% | 5.36% | 5.73% | 5.95% | 3.34% | 5.91% | 4.73% | 5.74% | 0.24% | 6.28% | 6.39% | 6.42% | 6.05% | 5.80% | 5.36% | 3.31% | 1.40% | 3.17% | 1.83% | 3.05% | -1.17% |
| EPS | -2.77 | -1.29 | -0.82 | -1.59 | -1.31 | -2.34 | -1.32 | -0.81 | -1.75 | 1.04 | 0.06 | -0.13 | 0.78 | 1.29 | 1.21 | 0.04 | -10.00 | 1.55 | 2.41 | 2.31 | 2.10 | 1.15 | 1.99 | 1.38 | 1.53 | 0.05 | 1.28 | 1.07 | 0.89 | 0.77 | 0.62 | 0.52 | 0.33 | 0.12 | 0.23 | 0.11 | 0.15 | -0.05 |
| EPS Diluted | -2.77 | -1.29 | -0.82 | -1.59 | -1.31 | -2.30 | -1.32 | -0.80 | -1.74 | 1.03 | 0.06 | -0.13 | 0.78 | 1.29 | 1.21 | 0.04 | -10.00 | 1.51 | 2.32 | 2.25 | 2.05 | 1.11 | 1.95 | 1.36 | 1.50 | 0.05 | 1.28 | 1.07 | 0.89 | 0.77 | 0.62 | 0.52 | 0.33 | 0.12 | 0.23 | 0.11 | 0.15 | -0.05 |
| Weighted Avg Shares Out | 36.52M | 35.27M | 34.38M | 33.64M | 33.54M | 32.75M | 32.47M | 32.17M | 32.01M | 31.92M | 31.64M | 31.96M | 32.39M | 31.97M | 31.90M | 31.84M | 31.79M | 31.56M | 31.15M | 30.86M | 30.87M | 30.62M | 30.13M | 30.14M | 29.93M | 29.57M | 30.39M | 30.08M | 29.66M | 28.81M | 28.71M | 27.33M | 23.11M | 22.55M | 22.28M | 22.28M | 22.28M | 22.22M |
| Weighted Avg Shares Out (Dil) | 36.52M | 35.27M | 34.38M | 33.64M | 33.54M | 33.22M | 32.59M | 32.68M | 32.20M | 32.04M | 31.87M | 31.96M | 32.69M | 32.00M | 31.95M | 31.93M | 31.79M | 32.45M | 32.35M | 31.73M | 31.66M | 31.68M | 30.76M | 30.62M | 30.58M | 30.37M | 30.39M | 30.08M | 29.66M | 28.81M | 28.71M | 27.33M | 23.11M | 22.55M | 22.28M | 22.28M | 22.28M | 22.22M |
Electric Wheelchair Market Report 2024-2031: Drive Medical Design & Manufacturing, Numotion, Invacare, and Sunrise Medical Dominate with 55-60% Share
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Electric Wheelchair Market Forecast 2024-2031" report has been added to ResearchAndMarkets.com's offering. The Global Electric Wheelchair Market is experiencing robust expansion, valued at US$ 7.3 billion in 2023, and projected to grow...
Electric Wheelchair Market Report and Company Analysis 2024-2032, Featuring Invacare, Sunrise Medical, Karman Healthcare, Pride Mobility Products Corp., Permobil, Sermax Mobility & Carex Health Brand
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Electric Wheelchair Market Report By Age group, Product, End Users, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering. The Electric Wheelchair Market is expected to experience substantial growth,...
YGGJ, KryptoGO, and IVC Launch Joint Venture, StickeyGO: Revolutionizing the GameFi Wallet Landscape
TAIPEI, June 12, 2023 /PRNewswire/ — StickeyGO, a joint venture company established by KryptoGO, YGG Japan (YGGJ), and Infinity Ventures Crypto (IVC), is thrilled to announce the launch of Stickey Wallet, a ground-breaking wallet specifically designed for the GameFi industry....
NYSE to Suspend Trading Immediately in Invacare Corporation (IVC) and Commence Delisting Proceedings
NEW YORK--( BUSINESS WIRE )--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of Invacare Corporation (the “Company”) — ticker symbol IVC...
Invacare files for bankruptcy, but expects to keep making and delivering home-care products
Invacare Corp. IVC, -2.25% said Wednesday it and two of its U.S.-based subsidiaries have filed for bankruptcy, as it implements a refinancing aimed at reducing net debt by about 65%. The stock is currently halted for news.
Invacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International Operations
ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) (“Invacare” or “the company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced actions to strengthen the company and position it for long-term success.
Invacare Corporation Announces Additional Draw of Term Loans
ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announced the consummation of an additional draw of $5,500,000 of term loans under to its Credit Agreement with certain funds managed by Highbridge Capital Management LLC (“Highbridge”), as...
Azurite Trims Invacare Stake after Inadvertently Passing 10% Ownership Trigger
Fintel reports that Rosen Steven H and his Azurite Management LLC filed a 13D/A form with the SEC disclosing ownership of 3,665,233 shares of Invacare Corporation (IVC cnx.cmd.push(function() {var videoId = decodeURIComponent(""); cnx({ playerId: "0a52d238-33b5-4c04-ba5e-323e192cfbe8", mediaId: videoId}).render("b8b49474e42e4a61905a1353db504ac9"); });).
Invacare Appoints Geoff Purtill President and Chief Executive Officer
ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named Geoffrey P. Purtill as President and Chief Executive Officer, roles that he has served on an interim basis since August 28, 2022.
Invacare Corporation (IVC) Q3 2022 Earnings Call Transcript
Invacare Corporation (NYSE:IVC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lois Lee - Director of Treasury, Investor Relations and Corporate Communications Geoffrey Purtill - Interim President and Chief Executive Officer Kathy Leneghan -...
Source: https://incomestatements.info
Category: Stock Reports